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Abstract Advances in the treatment of the human immuno-
deficiency virus (HIV) have dramatically improved survival
rates over the past 10 years, but HIV-associated neuro-
cognitive disorders (HAND) remain highly prevalent and
continue to represent a significant public health problem.
This review provides an update on the nature, extent, and
diagnosis of HAND. Particular emphasis is placed on
critically evaluating research within the realm of cognitive
neuropsychology that aims to elucidate the component
processes of HAND across the domains of executive
functions, motor skills, speeded information processing,
episodic memory, attention/working memory, language,
and visuoperception. In addition to clarifying the cognitive
mechanisms of HAND (e.g., impaired cognitive control),
the cognitive neuropsychology approach may enhance the
ecological validity of neuroAIDS research and inform the
development of much needed novel, targeted cognitive and
behavioral therapies.
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The Centers for Disease Control and Prevention (CDC 2006)
estimate that over 1 million individuals in the United States
(U.S.) are infected with the human immunodeficiency virus
(HIV), which affects nearly 33 million people world-wide
(United Nations 2007). In the U.S. and other developed
countries, survival rates associated with HIV infection have
improved dramatically since the introduction in 1996 of
combination antiretroviral therapies (cART), which are
capable of reducing viral burden, raising cluster of
differentiation 4 (CD4) cell counts, reducing opportunistic
infections, and improving health-related quality of life (e.g.,
Powderly 2002). Despite these remarkable improvements in
immune health outcomes, HIV-associated neurocognitive
disorders (HAND) remain a significant public health
concern. Although neurocognitive impairments are not
universal among HIV infected persons, clinically obvious
signs and symptoms of at least mild neurologic disease are
found in approximately 30% of persons with asymptomatic
HIV infection and about 50% of individuals with the
acquired immunodeficiency syndrome (AIDS) (Heaton
et al. 1995). While the incidence of the most severe form
of HAND, HIV-associated dementia (HAD), has declined
in the era of cART (e.g., Sacktor et al. 2001), the incidence
and prevalence of milder forms of HAND have been
relatively stable (McArthur 2004) and may have even
increased in individuals who are not immunosuppressed
(e.g., Grant et al. 2005). The intention of this review is to
provide an update on the nature, extent, and cognitive
mechanisms of HAND. We will touch briefly on issues of
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neurobiology, cART, comorbidities, and everyday function-
ing throughout this review. The reader is referred to the
companion articles within this special issue for in-depth
discussions of these important topics.
Although numerous excellent review articles and meta-
analyses have been published on the neurocognitive
aspects of HIV (e.g., Reger et al. 2002; Grant 2008), a
unique aspect of this review is the focus on the cognitive
neuropsychology of HAND. By cognitive neuropsychology,
we mean the use of theoretical models from cognitive psycho-
logy and the cognitive neurosciences to test hypotheses
regarding the component processes, mechanisms, and associ-
ated underlying neural systems of HAND. The first National
Institute of Mental Health (NIMH) workgroup on neuroAIDS
endorsed this approach, noting that: “new experimental
paradigms borrowed from cognitive psychology should be
represented in the (neurocognitive) battery” (Butters et al.
1990). Although the early years of neuroAIDS research were
appropriately focused on the use of traditional neurocogni-
tive approaches to examine the incidence, prevalence, and
general profile of HAND, the past 15 years have seen an
influx of studies applying the cognitive neuropsychology
approach. In addition to clarifying the cognitive mechanisms
of HAND (and neurotropic viruses more generally), the
cognitive neuropsychology approach may improve the pre-
dictive, discriminant, and ecological validity of neuropsy-
chology as pertains to the clinical assessment and remediation
of HAND (Poreh 2000).
HIV-Associated Neurocognitive Disorders (HAND)
A Brief History of HAND
Very early in the AIDS epidemic, clinicians noticed promi-
nent “organic”mental and neurological symptoms in a subset
of patients with advanced disease (e.g., Perry and Jacobsen
1986; Snider et al. 1983), suggesting that the underlying
pathogen (not known to be HIV at the time) likely affected
the central nervous system (CNS). Snider and colleagues
(1983) are credited with the first systematic description of
the CNS complications of AIDS in a case series of 50
patients, a proportion of whom exhibited possible AIDS-
related dementia. In these early years, patients with cognitive
impairment were often severely demented, which was viewed
as a harbinger of imminent mortality. Although these initial
studies of the AIDS dementia complex (ADC) described the
clinical onset of symptoms as insidious in most cases, many
dementia cases had abrupt accelerations sparked by opportu-
nistic infections (or pulmonary infections with hypoxia),
thus obscuring conclusions regarding a possible direct rela-
tionship between HIVand cognitive deficits (e.g., Navia et al.
1986). The existence of neurocognitive impairment directly
attributable to HIV, especially in the medically asymptom-
atic phase of disease, was somewhat controversial until
1987, when Grant et al. published the first comprehensive
study of HIV-associated neurocognitive deficits. Findings
from this study provided strong evidence of objective
neurocognitive impairment across all stages of HIV disease
(i.e., medically asymptomatic, symptomatic, and AIDS) and
in multiple ability areas, including executive functions,
episodic memory, and information processing speed.
Soon thereafter, the AIDS Task Force of the American
Academy of Neurology (AAN) (1991) convened to outline
diagnostic guidelines for classifying the neurologic com-
plications of HIV infection. At that time, two levels of
disturbance were proposed: 1) HIV-associated dementia
(HAD) with motor, behavioral/psychosocial, or combined
features; and 2) minor cognitive motor disorder (MCMD).
To meet criteria for a diagnosis of HAD a patient needed to
demonstrate an acquired deficit in at least two neuro-
cognitive domains that caused impairment in work or
activities of daily living (ADLs), as well as evidence of an
abnormality in motor abilities or specified neuropsychiatric
or psychosocial functions (e.g., motivation, lability, and
social behavior). MCMD described a less severe presentation
of HIV-associated neurocognitive impairment that did not
meet criteria for HAD, but was marked by impairment in at
least two neurocognitive or behavioral areas that produced a
decline in ADLs. In 1995, Grant and Atkinson expanded the
AAN system to include an additional diagnosis of “sub-
syndromic neurocognitive impairment” to characterize
patients who demonstrated mild neurocognitive deficits that
do not noticeably interfere with ADLs, a diagnosis which
became increasingly more recognized in neuroAIDS re-
search laboratories and clinics.
While the modified AAN criteria (Grant and Atkinson
1995) were reasonably accurate in predicting presence of
HIV-associated neuropathologies (e.g., Cherner et al. 2002),
researchers and clinicians alike have since recognized the
need to update and further structure the diagnostic criteria
for HAND, especially in light of the changing epidemiology
of HIV infection (Antinori et al. 2007). First, the applica-
bility of the old criteria is now limited in the present age of
cART. Prior to the advent of cART, a diagnosis of HAD was
associated strongly with low T-cell counts, high viral loads,
and opportunistic infections. With cART moderating viral
severity, persons with HIV typically live longer with milder
medical symptoms. Although cART initiation has been
linked to cognitive improvement and decreased incidence of
HAND (e.g., Brodt et al. 1997; Sacktor et al. 1999; 2001),
yearly incidence rates are still 10–25%, suggesting that a
variety of factors (e.g., immunological, genetic, psychosocial)
may also play an important role in determining cognitive
impairment (Robertson et al. 2007). Secondly, the modified
AAN criteria (Grant and Atkinson 1995) did not provide
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specific guidelines for the assessment and determination
of neurocognitive impairment. Considering the increased
prevalence of HIV infection since the early diagnostic
criteria and corresponding incident growth of cognitive
sequelae, standardization became increasingly necessary in
order to better address risk characteristics and treatment
possibilities. Finally, guidelines regarding possible neuro-
cognitive impairment due to comorbid conditions with CNS
effects (e.g., substance use disorders) were necessarily vague
in the previous diagnostic scheme, which diminished
interrater reliability of HAND (Woods et al. 2004b). This
caveat is particularly important in the era of cART as those
infected with HIV began living longer with a host of CNS
risk factors, including comorbid infectious diseases (e.g.,
hepatitis C virus), substance use disorders (e.g., metham-
phetamine dependence), and medical conditions associated
with cART treatment (e.g., hyperlipidemia).
Current Diagnostic Nomenclature of HAND
To address the concerns of definitions and causes of neuro-
cognitive impairment in HIV-infected individuals, the
nosology of HAND was recently revisited and subsequently
amended using recommendations from an NIH working
group (Antinori et al. 2007). As displayed in Fig. 1, the
redefined criteria allow for three possible research diagnoses:
1) asymptomatic neurocognitive impairment (ANI); 2) HIV-
associated mild neurocognitive disorder (MND); and 3)
HAD. The diagnosis of HAND must be determined by
assessing at least five areas of neurocognitive functioning
known to be affected by HIV infection (e.g., executive
functions, episodic memory, speed of information process-
ing, motor skills, attention/working memory, language,
and sensoriperception). Ideally, these domains would be
evaluated using a performance-based neurocognitive battery
and interpreted using demographically-appropriate norma-
tive data, although the criteria allow for use of mental status
exams, such as the HIV Dementia Scale (Morgan et al. 2008;
Power et al. 1995) in resource-limited settings. If observed,
neurocognitive impairment cannot be assigned a HAND
diagnosis if it is solely attributed to a comorbid condition
(e.g., psychosis or substance use) or delirium. Due to the
high prevalence of CNS comorbidities in HIV populations,
the updated criteria specify guidelines for dealing with
incidental (e.g., an individual with remote history of sporadic
methamphetamine use that is unlikely to have residual
cognitive effects), contributing (e.g., an individual with
methamphetamine dependence within one year, but who is
exhibiting clear signs of HIV-related cognitive decline), and
confounding (e.g., an individual who is acutely intoxicated
on methamphetamine) conditions.
As a diagnosis of HAND often rests on determining the
presence (or absence) of declines in everyday functioning,
it is important to consider the many intricacies and
complications involved in assessing functional impairment.
Currently, there are no widely agreed-upon clinical mea-
sures of everyday functioning (see Morgan and Heaton
2009). Performance-based assessments of everyday func-
tioning are sometimes used in research settings, but the lack
of normative data coupled with lengthy administration
protocols make it unlikely that the currently available mea-
sures would be widely used in a clinic setting (Moore et al.
2007). More commonly, assessments of everyday function-
ing rely on self-report, using questionnaires such as Lawton
& Brody’s modified Activities of Daily Living scale
(Heaton et al. 2004) and the Patient’s Assessment of Own
Functioning (PAOFI; Chelune et al. 1986). In some cases,
proxy (e.g., significant others and caregivers) reports may
complement patient report, particularly in cases of cognitive
impairment and poor insight. Similarly, self-reported func-
tional abilities are oftentimes confounded by psychiatric
(e.g., over-reporting due to depressive symptoms) or socio-





















































Fig. 1 Proposed decision-tree for diagnosing HIV-associated Neuro-
cognitive Disorders (adapted from Antinori et al. 2007 and Woods
et al., in press)
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responsibilities) factors, which must be carefully considered
in assessing self-report validity.
Asymptomatic Neurocognitive Impairment (ANI)
Considering the growing literature on mild neurocognitive
impairment in the absence of declines in everyday function-
ing, asymptomatic neurocognitive impairment (ANI) was
added as a diagnosis consistent with earlier references to
subsyndromic neurocognitive impairment (i.e., Grant and
Atkinson 1995). This previously unclassified contingent is
estimated to represent the majority of cases of HAND (i.e.,
over 50% of diagnosed cases) and 21–30% of the asymp-
tomatic HIV-infected individuals (Robertson et al. 2007).
The clinical significance of such “subsyndromic” impair-
ment is less well-established, although it has been associated
with neuropathologic abnormalities (Masliah et al. 1997;
Cherner et al. 2007) and an increased risk of early mortality
(Ellis et al. 1997). Detecting patients with mild, yet demon-
strable, neurocognitive impairment (i.e., > 1 SD below the
mean of demographically-adjusted normative scores in at
least two cognitive domains) may assist in the effort to pre-
identify those at risk for more significant cognitive as well
as functional decline, before cognitive deficits contribute to
a decline in everyday functioning with serious medical
consequences (e.g., medication nonadherence). In principle,
as effective treatments for neurologic complications are
developed, intervention at this earliest stage of HAND might
stand the best chance to effect remission, or at least, prevent
progression.
Mild Neurocognitive Disorder (MND)
Formerly referred to asMCMD,mild neurocognitive disorder
(MND) requires mild-to-moderate neurocognitive impair-
ment (i.e., > 1 SD below the mean of demographically-
adjusted normative scores) in at least two cognitive domains
in addition to mild everyday functioning impairment.
Approximately 30–50% of persons with a HAND diagnosis
experience some degree of functional impairment and it is
estimated that 20–40% of HAND diagnoses are of MND,
which comprises 5–20% of the HIV population overall. The
prevalence of MND is estimated between 5% to 14% in
individuals with early symptoms and approximately 25% of
those with AIDS (Goodkin et al. 2001; Grant and Atkinson
1999). Mild functional impairment can be classified as
meeting at least two of the following criteria: 1) self- or
proxy-report of declines in ≥ 2 instrumental activities of
daily living (IADLs; e.g., financial management); 2) unem-
ployment or a significant reduction in job responsibilities
secondary to reduced cognitive abilities; 3) decline in
vocational functioning (e.g., increased errors, decreased
productivity, or greater effort is required to achieve prior
levels of productivity); 4) self- or proxy-report of increased
problems in ≥ 2 cognitive ability areas in day-to-day life
(this criterion cannot be used if based only on the self-report
of an individual with current depression, since depression
may bias self-report); or 5) scores > 1 SD below the mean
on a performance-based laboratory measure of everyday
functioning (e.g., medication management).
HIV-Associated Dementia (HAD)
The most severe form of HAND, HIV-associated dementia
(HAD) is marked by at least moderate-to-severe cognitive
impairment (i.e., ≥ 2 SDs below demographically-adjusted
normative means) in at least two cognitive domains along
with marked ADL declines that are not fully attributable to
comorbidities or delirium. Additionally, HAD represents the
most severe form of HAND in terms of its functional impact,
which requires two or more of the following: 1) unemploy-
ment due to cognitive impairment; 2) self- or proxy-report of
dependence in > 2 IADLs related to cognitive problems; 3)
self- or proxy-report of declines in ≥ 4 cognitive ability areas
in day-to-day life (NB. As with a diagnosis of MND, this
criterion is not applicable if based exclusively on the self-
report of an individual with current depression); 4) perfor-
mance that is > 2 SD below the mean on a performance-based
laboratory measure of everyday functioning (or > 1 SD below
the mean on two functional tests). Reports from the early
1990’s placed an extremely wide range, 6–30%, on the
prevalence of HAD among persons with AIDS (Day et al.
1992; McArthur et al. 1993; Maj et al. 1994). After the
advent of cART in the late 1990’s, estimates appeared to
shift downward with approximately 4% to 7% of persons
with AIDS (Grant and Atkinson 1999), with more recent
appraisals suggesting that as few as 1% to 2% of HIV+
persons meet criteria for HAD (Grant et al. 2005).
The Course of HAND
Unlike other neurodegenerative disorders, such as Alzheimer’s
and Huntington’s diseases, HAND is not invariably progres-
sive and is therefore not an immutable diagnosis. Indeed,
there is tremendous variability in the course of HAND, with
evidence now showing that individuals may display consid-
erable recovery of cognitive functions (e.g., with effective
cART), incident worsening of HAND (e.g., with advancing
disease), static neurocognitive impairment, sustained nor-
mality (e.g., Cole et al. 2007), or a fluctuating course.
Robertson et al. (2007) showed that, of HIV-infected
persons who were unimpaired at their baseline visit, 21%
experienced incident neurocognitive impairment over a
relatively brief follow-up period. However, most persons
with incident HAND are initially classified with mild
impairment; that is, it is rare for persons in the current era
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of cART to transition from unimpaired to moderately or
severely impaired in a year (e.g., McArthur 2004). A
finding that is becoming increasingly apparent with regard
to the course of HAND is that a significant proportion of
individuals will improve neurocognitively. In the Robertson
et al. (2007) study, of those persons with HAND at baseline,
56% remained impaired whereas 44% no longer met criteria
for impairment. Furthermore, the likelihood of transitioning
from milder neurocognitive impairment to unimpaired
(21%) appears to be as likely as transitioning from unim-
paired to mild neurocognitive impairment (23%) (McArthur
2004). Nevertheless, it is difficult to interpret the data on
incident HAND, especially considering the complications of
practice effects (e.g., Woods et al. 2005b) that, if uncorrected,
may inflate the rates of observed improvement (and perhaps
also dampen the rates of incident impairment). The incidence
data are also confounded by the necessary use of cutpoints
for the classification of neurocognitive impairment (Carey
et al. 2004), which are highly susceptible to mis-classification
errors secondary to normal test-retest variability.
Neural Systems of HAND
A review of HIV-infected individuals at autopsy showed
that the brain is the second most frequently infected organ
after the lungs (Masliah et al. 2000). HIV often targets the
CNS because neural cells and microglia resident in the brain
can express chemokine receptors (e.g., CXCR4) receptors
that are necessary for HIV entry into cells (see Hult et al.
2008 for a review). Considerable evidence suggests that
HIV preferentially disrupts the fronto-striato-thalamo-
cortical loops. However, unlike some other neurodegener-
ative disorders where the pathology is endogenous and may
have a genuine affinity for a specific brain region (e.g., the
substantia nigra in the initial stages of Parkinson’s disease),
HIV also affects the structure and function of other white
matter tracts and neural systems, including the temporal
(e.g., hippocampus) and parietal cortices (e.g., Thompson
et al. 2005). One reason for the lack of regional specificity
is that the virus infiltrates the CNS by crossing the blood-
brain barrier (BBB) within monocyte derived macrophages
and/or monocytes via a “Trojan Horse” mechanism (Hult
et al. 2008). Although HIV does not necessarily infect
neurons, once across the BBB, the virus can produce
synaptodendritic injury through a host of different direct
(e.g., viral proteins) and indirect (e.g., neuroinflammatory)
mechanisms (see Hult et al. 2008), which can result in
damage to a variety of neural systems. Some have
hypothesized that the basal ganglia may be affected earlier
in the illness, with neocortical regions affected only with
more advanced disease. However, clinico-pathologic studies
of HIV+ persons with less advanced disease and an absence
of opportunistic infections are often difficult to conduct
given that these very factors typically represent a primary
cause of mortality (Moore et al. 2006). Further complicating
matters is that the neuropathogenesis of HIV may be
changing as the acute and more rapidly developing dele-
terious indirect cascade of events caused by HIV infection
noted in the early years of the pandemic may be giving way
to a chronic mild inflammatory state made possible by the
effectiveness of cART in permitting long term survival
(Foley et al. 2008). In fact, it has been noted that whereas
classical HIV-associated brain pathology (i.e., evidence of
HIV encephalitis, such as microglial nodules) may be less
prevalent in the post-cART era (see Ellis et al. this issue),
other evidence of brain injury remains prevalent, including
loss of synapses and dendrites, and, in some cases, focal or
diffuse inflammatory change in the white matter, and microvas-
cular pathology. Ongoing neural injurymay be driven by chronic
inflammation, occasioned by some combination of low-level
viral replication in the CNS or abnormal immune activation
triggered by HIV, may persist despite good virologic control.
Further neural injury may be amplified by cofactors such as
drugs of abuse, co-infections (e.g., hepatitis C), and aging.
With these caveats in mind, much attention has been
given to the examination of the structure and function of
subcortical regions among HIV-infected persons, most
notably the basal ganglia. These data generally suggest
that, although HIV may affect multiple brain regions, the
neurotoxic effects of the virus are most prominent in the
basal ganglia, as well as the frontal neocortex and the white
matter tracts connecting these regions. For example, sub-
cortical regions (e.g., caudate and putamen) may have higher
viral loads than cortical regions among individuals with HAD
(Fujimura et al. 1997; Wiley et al. 1998). Morphometric
analysis, using magnetic resonance imaging (MRI), has
shown decreased volume of the basal ganglia in advanced
HIV disease (Jernigan et al. 1993), including HAD (Aylward
et al. 1993). Masliah et al. (1996) noted ‘extensive loss’ of
microtubule-associated protein 2 (MAP2) -immunoreactive
neurons and dendrites in the basal ganglia of individuals with
HIV encephalitis (HIVE). Additional correlative imaging
studies have shown a relationship between caudate volume
loss and deficits in motor skills, information processing speed,
verbal fluency, and complex attention (Kieburtz et al. 1996).
More recent studies have revealed associations between
microstructural abnormalities in the basal ganglia (i.e.,
caudate and putamen) and HIV-associated cognitive impair-
ment (e.g., episodic memory) (Ragin et al. 2005). Proton
magnetic resonance spectroscopy (MRS) studies have also
confirmed greater disruption in the basal ganglia of
cognitively impaired HIV+ persons (Paul et al. 2007).
There is also significant evidence suggesting that HIV
affects the frontal cortex. Frontal dysfunction has been
interpreted as a consequence of late stage HIV disease and
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may be secondary to basal ganglia pathology (Rottenberg
et al. 1987). In the presence of HIVE, Masliah et al. (1995b)
found that neurons in neocortex were significantly reduced.
Subsequent clinico-pathologic studies have shown associa-
tions between cortical neurodegeneration and HIV-associated
global neurocognitive impairment (Everall et al. 1999;
Masliah et al., 1997). For example, Moore et al. (2006)
confirmed a univariate association between frontal neuro-
degeneration and neurocognitive impairment. However,
when additional brain regions were examined using multi-
variate statistical approaches, synaptodendritic loss in the
putamen and hippocampus were the sole independent
predictors of neurocognitive deficits, with a suggestion that
cortical and subcortical pathologies might evolve along separate
trajectories in some individuals. Indeed, despite the absence of
traditional cognitive markers of hippocampal neurodegenera-
tion in HIV (i.e., rapid forgetting), there is considerable
neuropathological evidence that hippocampal neurons are
affected in advanced HIV disease (Kruman et al. 1998; Masliah
et al. 1992). A similar story emerges when one examines the
possible contribution of parietal pathology to neurocognitive
impairment in HIV (e.g., Thompson et al. 2005).
Therefore, it may be that the expression of HIV-associated
cognitive deficits is driven by dysregulation of broader neural
networks that depend on the integrity of the frontostriatal loops
(e.g., frontotemporal and frontoparietal systems), rather than
by isolated frontal systems pathologies alone (e.g., Castelo
et al. 2006). In fact, perhaps the most consistent finding
among the neuroimaging and neuropathological studies of
HIV+ persons in the post-cART era is the involvement of
cerebral white matter, which may disrupt the functional
connectivity of the basal ganglia and neocortex. HIV-
associated white matter abnormalities are diffuse, but often
include frontal white matter and subcortical pathways (e.g.,
internal capsule), and may reflect synaptodendritic injury
severity (Archibald et al. 2004). Moreover, decreased n-
acetylaspartate (NAA, a marker of neuroaxonal injury) is
commonly observed in the white matter of the basal ganglia
and frontal cortex (e.g., Ernst and Chang 2004; Paul et al.
2008) and has been related to neurocognitive impairment,
including deficits in motor skills (Paul et al. 2007). Diffusion
tensor imaging (DTI) studies have revealed microstructural
abnormalities in the white matter (i.e., increased mean
diffusivity and reduced fractional anisotropy), which are
more prominent in persons with advanced disease (Filippi
et al. 2001; Pfefferbaum et al. 2007) and HAND (e.g.,
Gongvatana et al. 2007a).
The Neurocognitive Profile of HAND
The diffuse nature of HIV-associated neuropathologies
creates notable challenges in directly translating such non-
specific neurobiological mechanisms of HIV into testable
hypotheses for studies of cognitive neuropsychology, which
is a method that relies heavily on the dissociability of
neural systems. Accordingly, HIV is limited as a disease
model for developing conceptual hypotheses regarding the
role(s) of specific brain systems in cognition, as might be
better accomplished in focal lesion samples or diseases in
which the pathology is more restricted in the early phases
of the illness (e.g., Huntington’s disease). Nevertheless,
such models are still applicable to the study of neuroAIDS
and provide useful conceptual frameworks for elucidating
the cognitive mechanisms of HAND, which may in turn
inform neurobiological investigations. In point of fact, early
observations that the neurobehavioral profile of HAND was
most consistent with that of other ‘subcortical’ disorders
(e.g., Huntington’s disease), with deficits especially in the
areas of motor skills, processing speed, and executive
functions (e.g., Grant et al. 1987; Price et al. 1988), helped
to guide subsequent neuroimaging and neuropathological
studies of HIV. Moreover, HIV affords the opportunity to
explore the possible unique and combined roles of specific
CNS biomarkers (e.g., markers of neuronal injury, inflam-
mation, astrocytosis, and neuroprotective factors in plasma
and cerebrospinal fluid [CSF]) in the expression of HAND,
which may also fuel the next generation of hypothesis-
driven studies within cognitive neuropsychology.
Motor Skills and Information Processing
Severe movement abnormalities, such as chorea, myoclonus,
dyskinesia, and dystonia, are not frequently observed in
association with HIV infection, but can occasionally emerge
in individuals with HAD (e.g., Mirsattari et al. 1999) or CNS
opportunistic infections that affect the nigrostriatal dopami-
nergic system (e.g., Tse et al. 2004). Clinically observable
extrapyramidal signs can be nevertheless apparent in HIV,
particularly in persons with advanced disease. Valcour et al.
(2008) found that older adults with HIV were dis-
proportionately impaired on the motor scale of the Unified
Parkinson’s Disease Rating Scale, most notably on measures
of bradykinesia, hypomimia, action/postural tremor, and
hand agility. More subtle motor abnormalities are also
oftentimes evident on electrophysiological measurements of
rapid alternating movements and finger contraction, which
have been touted as particularly sensitive markers of HAND
(e.g., Arendt et al. 1990).
It is widely held that bradykinesia (i.e., slowed movement)
and bradyphrenia (i.e., slowed information processing) are
the most prominent features of neuroAIDS. As noted above,
motor slowing was a required feature of HAD in the early
diagnostic formulations (AAN 1991). In fact, some authors
have argued that bradykinesia and bradyphrenia are the
cardinal symptoms of HAND (Hardy and Hinkin 2002) and
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may even underlie deficits observed in neurocognitive
domains that are not expressly speeded (e.g., Becker and
Salthouse 1999). HIV-associated motor slowing is often
seen in gait velocity (e.g., Robertson et al. 2006), finger
tapping (e.g., Heaton et al. 1995), and manual dexterity
(e.g., grooved pegboard; Carey et al. 2004). Slowed infor-
mation processing speed is present on tasks with (e.g.,
Trail-making) and without (e.g., Stroop Color-Word) motor
demands.
HIV-associated cognitive and motor slowing deficits
are oftentimes exacerbated when controlled processing
demands are increased, such as under conditions of divided
attention (e.g., Martin et al. 1999). Despite the prominence
of basic and complex motor deficits in HIV, research on its
component process and underlying cognitive mechanisms
is relatively scant. Indeed, psychomotor speed is an ill-
defined cognitive construct as deficits may emerge from a
variety of CNS insults, and most of the available tests are
multifactorial. Even the term ‘psychomotor speed’ implies a
potpourri of related, but separable cognitive constructs
typically poorly articulated (e.g., reaction time studies often
use ‘time’ as an indicator of varying demands of test
conditions, such as divided attention, than speed per se).
Furthermore, impaired performance on traditional tests of
information processing speed could arise from a variety of
deficits, including attention (e.g., sustained or divided
attention), visuoperception, working memory, praxis, and
basic motor skills. To this end, Sassoon et al. (2007) found
that HIV-associated impairment on the Digit Symbol test
may emerge secondary to basic motor slowing, even after
considering the effects of executive functions, visuocon-
struction, and memory. More hypothesis-driven research on
the underlying component processes of HIV-associated
motor and information processing slowing is needed,
particularly considering research showing that such deficits
are reliable predictors of a variety of daily functioning
outcomes, including adherence (Waldrop-Valverde et al.
2006), automobile driving (Marcotte et al. 1999), and
health-related quality of life (e.g., Parsons et al. 2006).
Learning and Memory
Episodic memory impairment is highly prevalent in HIV,
with most estimates ranging from 40 to 60% (e.g., Heaton
et al. 1995; Rippeth et al. 2004). HIV-associated deficits in
episodic memory are readily observed on a variety of verbal
(e.g., word lists and passages) and visual (e.g., simple and
complex designs) tasks. Along with psychomotor slowing,
deficits in episodic memory are arguably one of the most
sensitive indicators of HAND (e.g., Carey et al. 2004). In
general, the level of impairment tends to be in the mild-to-
moderate range but may increase to moderate-to-severe in
patients with advanced HIV disease (Reger et al. 2002),
especially HAD (e.g., Scott et al. 2006). At the group level,
the pattern of HIV-associated episodic memory deficits is
most consistent with a mixed encoding and retrieval profile
(Delis et al. 2000), although there is considerable variability
between individuals (Murji et al. 2003). Approximately 30–
40% of HIV-infected patients demonstrate this profile (e.g.,
Becker et al. 1995; Delis et al. 1995), which is charac-
terized by impaired immediate and delayed free recall in the
setting of relatively better recognition performance (Woods
et al. 2005c). By contrast, only a small proportion of HIV-
infected persons display evidence of rapid forgetting, which is
sometimes evident in persons with HAD, perhaps secondary
to shallow encoding as indicated by elevated recency effects
(Scott et al. 2006). Although mild deficits may be evident on
recognition testing (e.g., Delis et al. 1995), this impairment
is thought to reflect inefficient higher-level encoding,
including source memory (Morgan et al. 2009). Numerous
studies show that HIV-associated deficits in free recall of
verbal material are marked by diminished use of strategic
organizational strategies, such as semantic clustering (e.g.,
Peavy et al. 1994), which may increase in magnitude with
the severity of HAND (Gongvatana et al. 2007b). At the
level of neural systems, this pattern of episodic memory
impairment is most consistent with a frontostriatal loop
pathogenesis (Castelo et al. 2006).
One aspect of episodic memory that is highly dependent
on frontal systems (e.g., Brodmann’s area 10) is prospective
memory, which entails one’s ability to successfully execute a
future intention (or more simply, ‘remember to remember’).
Prospective memory is a multifaceted construct involving the
formation, maintenance, retrieval, and execution of a future
intention, vis-à-vis ongoing mental activities that prevent
continuous rehearsal of that intention. HIV infection is
associated with frequent prospective memory complaints,
particularly in aspects of daily functioning that require self-
initiated cue monitoring and retrieval (Woods et al. 2007).
Moreover, individuals infected with HIV demonstrate mild-
to-moderate impairment on performance-based tests of
prospective memory, including both time- (e.g., Martin
et al. 2007) and event- (Carey et al. 2006) based tasks. The
profile of HIV-associated prospective memory impairment is
characterized by deficits in the strategic encoding (i.e.,
intention formation), monitoring, and retrieval of future
intentions, as evidenced by elevated rates of omission and
perseverative errors in the setting of normal recognition
(Carey et al. 2006).
Although prospective memory places demands on retro-
spectivememory and executive functions (e.g., set switching),
HIV-associated prospective memory impairment may never-
theless be singly dissociable at the neurobiological (e.g.,
Woods et al. 2006b), cognitive (e.g., Gupta et al., in press),
and functional (e.g., Woods et al. 2008a, b) levels. Prospec-
tive memory is endemic to independent living, playing a
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critical role in such essential daily tasks as employment,
household responsibilities (e.g., financial management), social
functioning, and health care (e.g., medical compliance). As
compared to global cognitive functioning, disease severity,
and psychiatric comorbidity, Assessment of prospective
memory deficits provides incremental ecological validity in
predicting general IADL declines (Woods et al. 2008a) and
medication mismanagement (Woods et al. 2008b) in HIV.
For example, Woods et al. (2009) found that HIV-infected
individuals with deficits in time-based prospective memory
(i.e., loss of time errors) were nearly six times more likely to be
non-adherent to their cART regimen than persons who
performed within normal limits, even after the possible
contributions of general cognitive impairment (e.g., retrospec-
tive memory) and psychiatric distress (e.g., depression) were
considered. Findings such as these illustrate the potential
benefits of applying novel theoretical models of cognition to
improve our ability to predict and ultimately remediate everyday
functioning deficits in persons living with HIV infection.
Prospective memory complaints are only weakly corre-
lated with performance-based deficits, suggesting that HIV-
infected individuals may not accurately perceive their
prospective memory functioning (Woods et al. 2007).
Indeed, there is broad evidence of a ‘meta-memory’ deficit
in HIV infection, which includes prospective memory as
well as retrospective memory (e.g., Hinkin et al. 1996).
HIV-associated meta-memory deficits are present in as
many as 35–60% of the infected population (e.g., Hinkin
et al. 1996; Rourke et al. 1999) and may be expressed as
either over- or under-reporting one’s actual level of memory
impairment. Over-reporting of HIV-associated memory prob-
lems is associated with affective distress, including depres-
sion (e.g., Rourke et al. 1999) and fatigue (e.g., Woods et al.
2007), where as under-reporting is more closely linked to
executive dysfunction (Rourke et al. 1999). It is possible
that such meta-memory deficits, and specifically under-
estimation of actual impairment, may amplify the risk of
functional impairment. For instance, an individual who
underestimates their current level of prospective memory
impairment may not choose to deploy necessary compensa-
tory techniques in their daily life, including tailored
mnemonic strategies, salient external reminders, and/or
request assistance from others (Knight et al. 2005). Because
the existing literature on HIV-associated meta-memory
deficits has only evaluated the relationship between com-
plaints and performance, further research is needed on the
strength (and mediators) of the association between expected
and actual memory performance.
Other aspects of declarative memory (e.g., semantic,
autobiographical, emotional) are quite poorly understood in
HIV infection and, considering the prevalence and functional
importance of HIV-associated episodic memory impairment,
represent an important direction for future research. With
regard to semantic memory, Sadek et al. (2004) reported
that HAD was associated with mild deficits in memory
for famous faces and public events, which in contrast to
Alzheimer’s disease, did not show a temporal gradient and
were generally comparable across time periods. Neverthe-
less, the HAD group displayed comparable remote memory
impairment to a demographically comparable sample of
patients with Huntington’s disease. Consistent with the
above-described profile of HIV-associated episodic memory
deficits, this pattern of impairment was hypothesized to stem
from deficient retrieval from semantic memory stores
secondary to frontostriatal circuit neurotoxicity.
Surprisingly, very few studies have examined the effects
of HIV on nondeclarative (i.e., implicit) memory, despite
the considerable literature on procedural learning and
priming in other diseases involving the basal ganglia, such
as Parkinson’s disease (e.g., Harrington et al. 1990). In
1993, Martin and colleagues suggested that HAND may
be associated with impaired motor skill learning, which
Kalechstein et al. (1998) later showed may be exacerbated
in individuals with comorbid depression. However, a larger
and more comprehensive study of substance abusers by
Gonzalez et al. (2008) revealed that, although HIV infection
was associated with slowed complex motor skills (e.g.,
rotary pursuit), there was no evidence of impaired proce-
dural learning per se. Although perceptual priming appears
to be spared in HIV infection, HAND is nevertheless
associated with deficits in semantic priming (e.g., Nielsen-
Bohlman et al. 1997). Highlighting the potential ecological
impact of nondeclarative memory impairment in HIV, Stacy
et al. (2006) found that measures of “spontaneous cogni-
tion” were predictive of HIV transmission risk behaviors in
a large sample of substance abusers.
Attention and Working Memory
Consistent with other neurocognitive domains, the severity
of attention/working memory impairment among indi-
viduals with HAND appears to be driven by HIV disease
severity as well as complexity or “load” of the attention/
working memory task. In early stages of HIV disease, basic
attention/concentration skills appear relatively spared
(Reger et al. 2002), but in later stage disease (e.g., CD4 <
200), mild-to-moderate deficits may appear in persons with
HAND (Reger et al. 2002; Brew 2004). Recent functional
neuroimaging studies suggest that the impairment in re-
sponse to increased attentional load may be associated with
increased frontoparietal activation (e.g., Chang et al. 2004).
While the bulk of attention-based research is derived from
traditional tests, such as digit span, digit vigilance (Heaton
et al. 1995), and continuous performance tests (Levine et al.
2006), attention is ostensibly a multidimensional construct
that requires further dissection. Most traditional measures
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of this ability are non-specific and have considerable
overlap with other cognitive functions, perhaps most
notably speed of information processing (e.g., Levine
et al. 2008). As such, several previous studies have used
the cognitive neuropsychology approach to clarify the
specific mechanisms of attentional deficits in HIV, revealing
impairment in the areas of divided attention (e.g., Hinkin
et al. 2000), orienting (e.g., Martin et al. 1995), and response
inhibition (e.g., Hinkin et al. 1999). A common theme of
these studies is that HIV is associated with mild deficits in
basic (i.e., automatic) attentional processes, which are
amplified when controlled processing demands are increased
(see also Hardy and Hinkin 2002). For example, Hinkin
et al. (2000) eported disproportionately slower simple and
choice reaction times in their HIV cohort under a dual (i.e.,
both auditory and visual choice paradigms) than a single task
condition. Nevertheless, as a result of the significant discrete
component attention difficulties observed among HIV+
persons, authors have argued that a clearer definition of
attention is necessary, one that more closely mirrors the
cognitive psychology definition of attention and suggests
that discrete component processes be examined (Levine et al.
2008). To this end, models such as that posed by Mirsky and
Duncan (2001), which suggest a five component processes of
attention (i.e., focus/execute, encode, shift, sustain, and
stabilize), may be applicable to neuroAIDS. Levine and
colleagues (2008) confirmed this five-factor solution in a
cohort of HIV+ persons; however, the authors are quick to
point out that the descriptors for the factors may not exactly
map onto the component processes of attention (e.g., as
mentioned above, the focus/execute component of attention
may more accurately be a measure of processing speed).
Nevertheless, investigations such as this may inform future
hypothesis-driven experiments that are strongly grounded in
cognitive theory and can carefully delineate the nature and
mechanisms of attentional deficits associated with HIV
infection.
In addition to studies of basic attention, there have been
several investigations into working memory (i.e., ability to
create a memory representation for temporary processing
and storage) abilities of HIV-infected persons that have
shown significant difficulties with both visual and verbal
working memory tasks (Bartok et al. 1997; Farinpour et al.
2000; Martin et al. 1995, 2001). From the perspective of
Baddeley and Hitch’s (1974) model of working memory,
several studies have hypothesized that HIV is primarily
associated with impairment in the central executive, rather
than the sensory slave systems (e.g., Hinkin et al. 2002b).
The observed central executive deficits in working memory
(e.g., increased load) have been linked to abnormal blood
oxygenation level-dependent (BOLD) signals in fronto-
parietal networks, likely secondary to inflammatory activa-
tion of glia (Ernst et al. 2003). Nevertheless, research is not
entirely consistent with regard to the primary involvement
of the central executive in HIV-associated working memory
impairment. For instance, it has been proposed that such
deficits may be driven by difficulties in maintaining
and storing representations, rather than central executive
processes (Bartok et al. 1997; Law et al. 1994; York et al.
2001). Considering Baddeley’s (2003) revisions to this
model, which now includes an episodic buffer that interacts
with the central executive and long-term memory, prospective
studies that employ rigorous experimental designs and
methods are needed to shed light on the component processes
of the widely-observed working memory deficit in HIV.
Further clarification of the cognitive mechanisms of the
HIV-associated working memory impairment is important
because deficits in this area can affect higher-level cog-
nitive abilities (e.g., decision-making; Martin et al. 2004)
and are associated with everyday functioning difficulties.
Specifically, Bassel and colleagues (2002) showed that
attention/working memory deficits, along with depression,
were among the strongest predictors of cognitive complaints
among HIV+ persons. Furthermore, Levine and colleagues
(2005, 2008) have shown attention (e.g., sustained attention)
to be predictive of medication adherence. Visual attention
abilities are also significantly associated with driving ability,
particularly the number of driving accidents in the past year
(Marcotte et al., 2004, 2006). Attention/working memory
deficits (along with executive functioning impairments)
were the strongest predictors of dependence in IADLs, as
well as a summary score of performance-based measures of
everyday functioning (Heaton et al. 2004). Studies that
combine a detailed cognitive neuropsychology approach
with comprehensive assessments of everyday functioning
may be able to uncover even stronger mechanistic associ-
ations that may be targets for neurocognitive interventions
and rehabilitation.
Executive Functions
According to Mega and Cummings (1994), executive
functions include complex problem solving abilities, self-
directed independent behaviors, and set shifting functions
among other abilities. Executive functions are often
assessed by measures of abstraction, problem solving, set
shifting and reasoning. Intact executive functions are most
notably dependant on the frontal cortex (especially the
dorsolateral prefrontal system), as well as the basal ganglia
and posterior parietal cortex (Stuss and Levine 2002). It is
widely accepted that HIV is associated with executive
dysfunction, especially in the later stages of disease (Reger
et al. 2002). A recent study using a cluster analysis
approach to uncovering neurocognitive impairments among
HIV+ persons showed that executive functions impairments
were a component of nearly all of the observed clusters
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suggesting that these impairments are central to most HIV
neurocognitive impairment profiles (Dawes et al. 2008).
Deficits in executive functions are strongly associated with
impairments in everyday functioning (Heaton et al. 2004).
There are numerous examples of studies that have used
standard neurocognitive measures to assess executive
functions among HIV+ persons. Deficits in abstraction
and novel problem solving are commonly observed on the
Halstead Category Test and the Wisconsin Card Sorting
Test (e.g., Grant et al. 1987; Heaton et al. 1995). Assess-
ments on the Stroop Color Word Test have reliably shown
that HIV+ persons were significantly slower as compared to
HIV- comparison participants, but the greatest difficulties
are apparent on the interference condition suggesting
deficient prepotent response inhibition abilities (Tozzi
et al. 1999; Hinkin et al. 1999). Set shifting differences
have been observed on the Wisconsin Card Sorting Test
(Carter et al. 2003) and Trail Making Test Part B (Heaton
et al. 1995; Reger et al. 2002). Deficits have also been
observed on measures of cognitive (Bartok et al. 1997) and
social planning (e.g., Benedict et al. 2000) among HIV+
persons. A more recent study suggests that HIV may be
associated with impairment in semantic event sequencing, the
neural substrates of which appear to involve the functional
connectivity of the prefrontal cortex (i.e., dorsolateral and
ventromedial regions) and basal ganglia (Melrose et al. 2008).
Given that some HIV+ persons became HIV infected due
to engagement in risky behaviors, there has been a particular
interest in tests that assess risky decision making, which is
hypothesized to assess frontal systems that may be
particularly disrupted among HIV+ persons. Deficits among
HIV+ individuals on the Iowa Gambling Test (IGT) have
been observed in two studies (e.g., Hardy et al. 2006; Martin
et al. 2004). Findings on the IGT suggest that HIV+ persons
have a propensity to choose larger, immediate rewards over
gradually-accumulated smaller rewards that result in in-
creased longer-term gains overall. These response styles
suggest more impulsivity among HIV+ persons, which may
directly relate to risky decisions in daily life (e.g., failure to
use a condom) (Martin et al. 2004). Furthermore, risky
decision-making may be related to sensation seeking among
HIV+ individuals and may represent a common patho-
physiology (Gonzalez et al. 2005).
As compared with other ability areas (e.g., memory and
language), relatively fewer studies have examined the
underlying component cognitive processes of executive
dysfunction in HIV. This is surprising given the wealth of
available conceptual models (see Stuss and Knight 2002),
as well as the prevalence of executive deficits and their
association with important functional outcomes, such as
medication adherence (e.g., Hinkin et al. 2002a). Process
analysis of clinical instruments, such as the Delis Kaplan
Executive Functions System (D-KEFS), may be particularly
useful in this regard. Furthermore, integration of novel
conceptual aspects of executive and frontal functions, such
as category learning, theory of mind, temporal perception
and sequencing, and multitasking, may also shed light on
the cognitive architecture of HIV infection.
Visuoperception
Considering the relative sparing of occipital and parietal
cortices in neuroAIDS, it has been widely held that spatial
cognition is largely unaffected in HIV infection. Large-scale
early investigations seemingly supported this hypothesis,
detecting no significant impairment in standard clinical tests
of visuospatial functioning (e.g., Heaton et al. 1995). How-
ever, recent meta-analyses of these early data have shown
mixed results (e.g., Reger et al. 2002; Cysique et al. 2006).
Most of these early investigations used batteries that were
limited in the breadth and depth of their assessment of spatial
cognition (e.g., Rey-Osterrieth figure copy only), thereby
raising the possibility that their null findings at the individual
study level may reflect Type II error. Indeed, a few small early
studies of HIV infection revealed evidence of possible mild
deficits in spatial cognition, including visuoconstruction
and visuospatial skills (Poutianinen et al. 1988).
Since these early studies, subsequent investigations have
examined select aspects of spatial cognition, defined as the
ability to detect, understand, manipulate, and integrate
visual stimuli in the context of its environment. A closer
review across studies examining a wider range of spatial
abilities indicates that subtle deficits are consistently
present, even in the absence of basic visual dysfunction.
Unsurprisingly, many of these studies noted that deficits
occur in spatial abilities that rely more heavily on the
integrity of fronto-striato-parietal networks. For example,
egocentric spatial tasks (i.e., tasks that relate to the
participant’s frame of reference, as opposed to that of an
observer) were differentially more impaired in HIV+
individuals than seronegative participants, and also as
compared to performance on extrapersonal tasks. HIV-
associated deficits in global versus local visual processing
(Martin et al. 1992), covert orienting (Maruff et al. 1995),
and perceptual span (Hardy et al. 2004) suggest the
presence of visual attention abnormalities that may increase
the risk of negative consequences in daily life (e.g.,
increase likelihood of automobile accidents; Marcotte
et al. 2006). Mental manipulations of objects and concepts
have been explored through two recent explorations in
asymptomatic HIV participants. Olesen et al. (2007)
described mental rotation deficits in a computerized task
examining reaction time and errors on mental rotation of
hands and 3D objects, in which group differences were
observed with increased task difficulty (i.e., greater degree
of rotation). More recently, Bogdanova et al. (2008) related
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errors on mental and physical number line orientation to
measures of component processes (e.g., executive func-
tions, visuospatial skills) and noted relative impairment in
visuospatial functioning among those with HIV.
Although these works support the likelihood that subtle
deficits exist in spatial cognition in HIV infection, the
underlying etiology is still unclear. Recent neuroimaging
research suggests that cortical thinning of parietal and frontal
lobes is associated with cognitive impairment (Thompson
et al. 2005). Whereas several groups have used significant
correlations between target tasks and supplementary mea-
sures of spatial cognition to support a possible posterior
parietal pathogenesis, the strong reliance on frontostriatal
pathways across tasks temper this argument (e.g., hierarchical
pattern processing, Olesen et al. 2007; spatial reasoning,
Bogdanova et al. 2008). As such, multidisciplinary, thorough
investigations of spatial cognition in HIV are still needed to
elucidate the nature and origin of impairment.
Speech and Language
Although language impairments, and particularly expres-
sive language difficulties, are a prominent cognitive feature
of HIV infection in children (e.g., Wolters et al. 1997), it
has long been held that HIV-infected adults demonstrate
broadly unremarkable speech and language functioning.
Indeed, aphasia is not typically observed in association with
HIV, with the exception of rare instances in which a CNS
opportunistic infection (e.g., progressive multifocal leuko-
encephalopathy) produces a perisylvian lesion (while CNS
opportunistic infections have declined in developed nations
due to cART, they remain prevalent in resource-limited
settings [see Robertson and Heaton 2009]). Despite this
widely held belief, we are unaware of any large-scale
studies examining the basic aspects of speech and language
in HIV infection and must therefore base our impressions
on the relatively few case series available in the literature.
For example, Lopez et al. (1994) found evidence of a mild
motor speech disorder in six patients with HIV that was
primarily characterized by ataxic dysarthria (e.g., irregular
articulatory rhythm). A more recent case series suggests
that subtle vocal abnormalities may also be observed in
HIV (e.g., Mathew and Bhat 2008), including reduced
volume of speech, shorter phonation duration, and mild
vocal tremor (Mathew and Bhat 2007).
Despite a relative paucity of empirical evidence, the
limited data available indicate that basic receptive (e.g.,
auditory comprehension) and expressive (e.g., repetition)
language functions are generally within normal limits in
HIV infection (e.g., McCabe et al. 2007), although mild
difficulties in the more complex aspects of expressive
language may be observed. If present, general expressive
language deficits tend to be mild in the asymptomatic stage
of disease, but may increase to medium effect sizes in
persons with AIDS (Reger et al. 2002). Despite these subtle
difficulties, formal assessment of confrontation naming
generally reveals normal performance (cf. Grohman et al.
2002), even among individuals with HAD (e.g., White
et al. 1997). Mild impairment in the pragmatic aspects of
communication may nevertheless be evident, including
turn-taking during conversations (e.g., inappropriate inter-
ruptions), poor lexical selection, and reduced fluency
(McCabe et al. 2007). Indeed, verbal fluency impairment
is the most frequently identified language deficit in HIV and
is estimated to occur in approximately 40% of the
population (Rippeth et al. 2004). Verbal fluency deficits
are generally mild but may increase to moderate severity
among individuals with more advanced HIV disease
(Iudicello et al. 2007). Regarding the profile of HIV-
associated verbal fluency impairment, a recent meta-
analysis showed generally comparable effect sizes for both
letter- and category-cued fluency tasks (Iudicello et al.
2007), which is consistent with meta-analytic findings in
other frontal systems conditions, such as frontal lobe
lesions (Henry and Crawford 2004). In fact, prior research
shows that HIV-associated verbal fluency deficits correlate
with neurodegeneration in frontostriatal systems, including
caudate atrophy (Hestad et al. 1993).
At the level of component cognitive processes, verbal
fluency deficits may arise from several different underlying
factors, including bradyphrenia, degraded semantic memory
stores, and/or inefficiencies in complex process of switching
between lexico-semantic categories during word retrieval
(Troyer 2000). Three studies have used Troyer’s (2000)
model of clustering (i.e., consecutively generated words
within a lexico-semantic category) and switching (i.e.,
disengaging from a cluster and identifying and accessing
another subcategory from which to generate words) to
evaluate the hypothesis that HIV-associated fluency deficits
may be a function of executive dyscontrol of switching
secondary to frontostriatal neurotoxicity. In an HAD sample,
Woods et al. (2004a) posited that HIV-associated verbal
fluency deficits were specifically driven by impairment in
the process of search and retrieval from lexico-semantic
memory stores, as indicated by impaired switching and
elevated intrusion errors (91% of which occurred in the
context of a phonemic switch) in the setting of spared
semantic clustering. Indeed, switching impairment was
evident even when corrected for overall word production,
suggesting that the switching finding was not simply an
artifact of cognitive slowing. In a subsequent study, Millikin
et al. (2004) reported that the letter and category fluency
deficits in patients with AIDS were driven by impairment in
switching, rather than clustering. Similarly, Iudicello et al.
(2008) observed impairment in category fluency switching,
but not clustering, in a sample of largely immunocompetent
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HIV-infected persons. Category switching deficits were
modestly correlated with measures of executive functions,
working memory, and semantic memory (i.e., confrontation
naming). Interestingly, an interaction was observed such that
the HIV-associated verbal fluency switching deficit was
exacerbated when an explicit alternating fluency paradigm
was used (Iudicello et al. 2008). Taken together, these
studies indicate that HIV-associated fluency deficits may be
primarily driven by difficulties switching between semantic
memory stores during word retrieval (cf. bradyphrenia or a
degradation of semantic memory), which may be a function of
executive dyscontrol of rule-guided search and retrieval
processes secondary to dysregulation of frontostriatal systems.
Moreover, the association between switching and measures of
semantic memory also suggests that, consistent with current
conceptual models of verbal fluency, there may be implications
for frontotemporal networks more broadly. Hypothesis-driven
neuropathological and neuroimaging (both functional and
structural) studies are needed to clarify the neural under-
pinnings of HIV-associated verbal fluency switching deficits.
Perhaps due to their generally mild severity, HIV-
associated verbal fluency deficits are only modest predic-
tors of everyday functioning outcomes. A recent series of
studies suggests that a relatively novel test of action (verb)
fluency (Piatt et al. 1999) may be more severely affected in
HIV (e.g., Woods et al 2005a) and may demonstrate
superior prediction of functional outcomes (Woods et al.
2006a) as compared to traditional verbal fluency measures
that use letter (e.g., FAS) and noun (e.g., animals,
supermarket items) retrieval cues. Action fluency (i.e.,
rapid oral generation of ‘things…that people do’) was
developed within the conceptual framework that the neural
networks involved in noun and verb processing are singly
dissociable (Damasio and Tranel 1993). Specifically, noun
generation is posited to rely primarily on temporoparietal
networks and semantic memory stores, whereas verb
generation places greater demands on frontal systems,
executive functions, and motor planning (e.g., Cappa and
Perani 2003). Action fluency is disproportionately affected
in HIV relative to the standard noun- and letter-based
fluency tasks (Cysique et al. 2007; Woods et al. 2005a) and
is impaired in approximately 60% of persons with HAND
(Woods et al. 2005a). Moreover, HIV-associated deficits in
action fluency may be dissociable from those in noun
fluency at both the cognitive and neurobiological levels.
As compared with noun fluency, action fluency correlates
more strongly with measures of motor coordination,
executive functions, and working memory in HIV (Woods
et al. 2005a). In addition, action fluency, but not noun
fluency, correlates with HIV biomarkers of astrocytosis
(i.e., elevated S-100β in the CSF), suggesting that the
neuropathogenesis of these impairments may be distinct
(Iudicello et al. 2008). Of arguably greatest importance,
action fluency demonstrates incremental ecological validity
versus letter and animal fluency as a predictor of IADL
dependence in HIV (Woods et al. 2006a). A recent study
showed that action fluency was approximately twice as
sensitive to IADL declines versus letter and animal fluency
combined; in fact, HIV-infected individuals who are
impaired on action fluency were five times more likely to
be IADL dependent than those who perform within normal
limits (Woods et al. 2006a). It is hypothesized that HIV-
associated action fluency deficits reflect inefficiencies
engaging motor representations during action retrieval,
which may therefore disrupt the generation and organiza-
tion of the action-based programs needed to function in
day-to-day life. Of course, these findings await replication
and further research is needed on the cognitive mechanisms
(e.g., switching) and neural substrates of action fluency
impairment in HIV.
Conclusions
Despite effective systemic treatments and improved survival
rates, the high prevalence and adverse functional impact of
HAND have endured in the cART era and continue to
represent a salient public health issue. Over the past 15 years,
substantial progress has been made in revealing the cognitive
architecture of HAND, the central mechanisms of which
appear to revolve primarily around psychomotor slowing
and cognitive control over mental operations, possibly
reflecting the influence of disrupted frontostriatal circuits
on distributed neural networks critical to cognitive functions
(e.g., frontotemporal and frontoparietal systems). Consider-
able work remains to be done in clarifying the cognitive
mechanisms of HAND, especially in identifying the compo-
nents of executive dysfunction (e.g., component processes
of planning deficits), which may play a central role in
numerous aspects of everyday functioning (e.g., medication
adherence). Moreover, surprisingly few studies have taken
advantage of the many advances in functional neuroimaging
that may illuminate the neural substrates of the cognitive
mechanisms of HAND, as well as provide the opportunity to
draw upon the rich cognitive neuroscience literature that has
yet to be applied to neuroAIDS research. Such efforts may be
useful in isolating the individual and combined cognitive
effects of common comorbidities, such as substance abuse
and aging, both of which may be fertile sources of hypothesis
generation (e.g., Hardy & Vance, this issue). Importantly, the
cognitive neuropsychology approach, particularly in the
areas of memory and language functioning, has already been
helpful in improving the ecological relevance of neuro-
cognitive assessments in HIV infection (e.g., Woods et al.
2009). Ultimately, this approach will be most useful when it
is designed to inform the development of novel, targeted
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cognitive and behavioral strategies to lessen the impact of
HAND on the day-to-day lives of individuals infected with
HIV, as well as their care providers. Indeed, there is a
paucity of research on the efficacy of cognitive and
behavioral remediations of HAND, which represents a
critical direction for future research efforts.
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